Laurel Wealth Advisors (North Carolina)’s CRISPR Therapeutics CRSP Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-100	Closed	-$3.94K	–	707
2024 Q4	$3.94K	Buy	+100	New	+$3.94K	﹤0.01%	579
2022 Q3	–	Sell	-100	Closed	-$6K	–	553
2022 Q2	$6K	Buy	+100	New	+$6K	﹤0.01%	418